PATHWAY-2: which agent can best treat therapy resistant hypertension?
Recorded at ESC 2015, August 31, 2015 in London, United Kingdom
Prof. Bryan Williams (University College London, United Kingdom)
Prof. Bryan Williams (Londen) presented the PATHWAY-2, in which 3 different additional agentsto treat therapy resistant hypertension were compared. Spironalactone clearly performed better than the other two.
The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.